Ready to submit bids? Probably not yet, but we are here to help! In this session, Milliman experts will highlight hot topics for Medicare Advantage Prescription Drug (MAPD) bid development in advance of the 2022 bid deadline. Attendees of this session will leave with a better understanding of key considerations for both Part C & D bids, along with insight on related party topics and changes to the bid instructions.
